Women who reached menopause before 40 faced a meaningfully higher risk of high blood pressure than those who went through menopause after 45, in a UK Biobank cohort study involving more than 107,000 women. The finding pushes premature menopause into cardiovascular risk territory, with blood pressure emerging as a marker that should be checked sooner, not left until later midlife.
The Menopause Society said the result applied to women who reach menopause before age 40 and described the risk as a “meaningfully higher risk” of developing high blood pressure. News-Medical’s coverage of the study said the association was strongest among women whose menopause arrived between ages 25 and 35, a particularly early window that sits well outside the usual menopause transition.
That distinction matters. The NHS defines early menopause as before 45 and premature menopause as before 40. The British Menopause Society puts the median age of menopause at 51 and says the transition lasts a median of 7.4 years, which means premature menopause can add years of exposure to the loss of ovarian hormones. In plain English, that longer hormone gap can affect blood vessels, arterial flexibility, cholesterol patterns and body composition, all of which feed into later heart and stroke risk.
The practical message is that menopause history belongs in routine cardiovascular assessment. A woman whose periods stop early because of natural menopause, surgery or medical treatment should not be treated as if the issue is only about fertility or hot flushes. For pharmacists, GPs and other frontline clinicians, a history of premature menopause or premature ovarian insufficiency should prompt an earlier blood pressure reading, review of lifestyle risk factors and follow-up on any broader cardiovascular concerns.
The cardiovascular link is not new, but it is widening. The American Heart Association linked early menopause with higher future coronary heart disease risk in 2021, and an American College of Cardiology summary this year said premature menopause was associated with increased lifetime coronary heart disease risk in Black and White women. Together, those findings strengthen the case for earlier screening in women with menopause before 45, especially before 40, so blood pressure is not the first warning sign to be noticed too late.